Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.

Komeda S, Yoneyama H, Uemura M, Muramatsu A, Okamoto N, Konishi H, Takahashi H, Takagi A, Fukuda W, Imanaka T, Kanbe T, Harusawa S, Yoshikawa Y, Yoshikawa K.

Inorg Chem. 2017 Jan 17;56(2):802-811. doi: 10.1021/acs.inorgchem.6b02239. Epub 2017 Jan 3.

PMID:
28045514
2.

Possibility of breast cancer prevention: use of soy isoflavones and fermented soy beverage produced using probiotics.

Takagi A, Kano M, Kaga C.

Int J Mol Sci. 2015 May 13;16(5):10907-20. doi: 10.3390/ijms160510907. Review.

3.

Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer.

Kaga C, Takagi A, Kano M, Kado S, Kato I, Sakai M, Miyazaki K, Nanno M, Ishikawa F, Ohashi Y, Toi M.

Cancer Sci. 2013 Nov;104(11):1508-14. doi: 10.1111/cas.12268. Epub 2013 Oct 20.

4.

PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse.

Konishi H, Takagi A, Kurita A, Kaneda N, Matsuzaki T.

BMC Cancer. 2012 Oct 10;12:462. doi: 10.1186/1471-2407-12-462.

5.

Antitumor activity of IHL-305, a novel pegylated liposome containing irinotecan, in human xenograft models.

Matsuzaki T, Takagi A, Furuta T, Ueno S, Kurita A, Nohara G, Kodaira H, Sawada S, Hashimoto S.

Oncol Rep. 2012 Jan;27(1):189-97. doi: 10.3892/or.2011.1465. Epub 2011 Sep 20.

PMID:
21935577
6.

Chemical synthesis of the 17-propanamide derivatives of stereoisomeric Δ14-17α- and 17β-estradiols: potential 17β-hydroxysteroid dehydrogenase inhibitors.

Iida T, Ogawa S, Tamegai H, Adachi Y, Saito H, Ikegawa S, Konishi H, Takagi A, Matsuzaki T.

Chem Phys Lipids. 2011 Feb;164(2):106-12. doi: 10.1016/j.chemphyslip.2010.11.005. Epub 2010 Dec 1.

PMID:
21129370
7.

Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse.

Takagi A, Ikemura H, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T.

J Gastroenterol. 2008;43(9):661-9. doi: 10.1007/s00535-008-2212-7. Epub 2008 Sep 20.

PMID:
18807127
8.

[Biological behavior of prostate cancer cells in 3D culture systems].

Watanabe M, Takagi A.

Yakugaku Zasshi. 2008 Jan;128(1):37-44. Review. Japanese.

9.

Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells.

Ngan CY, Yamamoto H, Takagi A, Fujie Y, Takemasa I, Ikeda M, Takahashi-Yanaga F, Sasaguri T, Sekimoto M, Matsuura N, Monden M.

Cancer Sci. 2008 Jan;99(1):129-39. Epub 2007 Oct 19.

10.

Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features.

Takagi A, Watanabe M, Ishii Y, Morita J, Hirokawa Y, Matsuzaki T, Shiraishi T.

Anticancer Res. 2007 Jan-Feb;27(1A):45-53.

11.

High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone.

Hirokawa YS, Takagi A, Uchida K, Kozuka Y, Yoneda M, Watanabe M, Shiraishi T.

Cell Mol Biol Lett. 2007 Sep;12(3):370-7. doi: 10.2478/s11658-007-0009-y. Epub 2007 Feb 17.

12.

Intestinal microflora: probiotics and autoimmunity.

Matsuzaki T, Takagi A, Ikemura H, Matsuguchi T, Yokokura T.

J Nutr. 2007 Mar;137(3 Suppl 2):798S-802S. doi: 10.1093/jn/137.3.798S. Review.

PMID:
17311978
13.

Knowledge of epigenetic influence for prostate cancer therapy.

Watanabe M, Takagi A, Matsuzaki T, Kami D, Toyota M, Hirokawa Y, Shiraishi T.

Curr Cancer Drug Targets. 2006 Sep;6(6):533-51. Review.

PMID:
17017872
14.

Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines.

Gu J, Yamamoto H, Lu X, Ngan CY, Tsujino T, Konishi K, Takemasa I, Ikeda M, Nagata H, Hashimoto S, Matsuzaki T, Sekimoto M, Takagi A, Monden M.

Digestion. 2006;74(1):19-27. Epub 2006 Sep 19.

PMID:
16988507
15.

Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.

Hata T, Yamamoto H, Ngan CY, Koi M, Takagi A, Damdinsuren B, Yasui M, Fujie Y, Matsuzaki T, Hemmi H, Xu X, Kitani K, Seki Y, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.

Mol Cancer Ther. 2005 Oct;4(10):1585-94.

16.

Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.

Fujie Y, Yamamoto H, Ngan CY, Takagi A, Hayashi T, Suzuki R, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.

Jpn J Clin Oncol. 2005 Aug;35(8):453-63. Epub 2005 Jul 15.

PMID:
16024531
17.
18.

Antitumor activity and action mechanisms of Lactobacillus casei through the regulation of immune responses.

Matsuzaki T, Takagi A, Ikemura H, Matsuguchi T, Yokokura T.

Biofactors. 2004;22(1-4):63-6.

PMID:
15630253
19.

Identification of differentially methylated CpG islands in prostate cancer.

Yamada Y, Toyota M, Hirokawa Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M.

Int J Cancer. 2004 Dec 10;112(5):840-5.

20.

Altered methylation of multiple genes in carcinogenesis of the prostate.

Yamanaka M, Watanabe M, Yamada Y, Takagi A, Murata T, Takahashi H, Suzuki H, Ito H, Tsukino H, Katoh T, Sugimura Y, Shiraishi T.

Int J Cancer. 2003 Sep 1;106(3):382-7.

Supplemental Content

Loading ...
Support Center